Paper29933129
Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3.
Greenall SA and 3 others. Transl Oncol, 2018. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3. Papers, record 29933129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29933129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10961344 | Structure and function of the type 1 insulin-like growth factor receptor. | Cell Mol Life Sci | 2000 | https://conductscience.org/library/papers/10961344 | PubMed |
| 2 | 9408744 | Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. | Endocr Rev | 1997 | https://conductscience.org/library/papers/9408744 | PubMed |
| 3 | 20515953 | A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo. | Mol Cancer Ther | 2010 | https://conductscience.org/library/papers/20515953 | PubMed |
| 4 | 12531883 | A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. | J Clin Invest | 2003 | https://conductscience.org/library/papers/12531883 | PubMed |
| 5 | 2546147 | Monoclonal antibodies to the insulin receptor mimic metabolic effects of insulin but do not stimulate receptor autophosphorylation in transfected NIH 3T3 fibroblasts. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2546147 | PubMed |
| 6 | 18089823 | PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib. | Cancer Res | 2007 | https://conductscience.org/library/papers/18089823 | PubMed |
| 7 | 10207053 | Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. | Mol Cell Biol | 1999 | https://conductscience.org/library/papers/10207053 | PubMed |
| 8 | 2837209 | Evidence of autocrine regulation in human hepatoma cell lines. | Biochem Biophys Res Commun | 1988 | https://conductscience.org/library/papers/2837209 | PubMed |
| 9 | 9707622 | Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9707622 | PubMed |
| 10 | 15019164 | Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II. | Cancer Lett | 2004 | https://conductscience.org/library/papers/15019164 | PubMed |
| 11 | 26429980 | Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade. | Clin Cancer Res | 2015 | https://conductscience.org/library/papers/26429980 | PubMed |
| 12 | 24747966 | Glioma-specific Domain IV EGFR cysteine mutations promote ligand-induced covalent receptor dimerization and display enhanced sensitivity to dacomitinib in vivo. | Oncogene | 2015 | https://conductscience.org/library/papers/24747966 | PubMed |
| 13 | 19762238 | Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs). | Bioorg Med Chem Lett | 2009 | https://conductscience.org/library/papers/19762238 | PubMed |
| 14 | 15964556 | Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. | Biochem Biophys Res Commun | 2005 | https://conductscience.org/library/papers/15964556 | PubMed |
| 15 | 19706799 | Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19706799 | PubMed |
| 16 | 18350600 | Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. | World J Gastroenterol | 2008 | https://conductscience.org/library/papers/18350600 | PubMed |
| 17 | 19646808 | Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis. | Cancer Lett | 2010 | https://conductscience.org/library/papers/19646808 | PubMed |
| 18 | 23166326 | Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancer. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23166326 | PubMed |
| 19 | 1377676 | A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. | J Biol Chem | 1992 | https://conductscience.org/library/papers/1377676 | PubMed |
| 20 | 2330056 | A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. | Nature | 1990 | https://conductscience.org/library/papers/2330056 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35799301 | Circular dorsal ruffles disturb the growth factor-induced PI3K-AKT pathway in hepatocellular carcinoma Hep3B cells. | Cell Commun Signal | 2022 | https://conductscience.org/library/papers/35799301 | PubMed |
| 35611205 | Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma. | World J Clin Cases | 2022 | https://conductscience.org/library/papers/35611205 | PubMed |
| 32033443 | The IGF-II-Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32033443 | PubMed |
| 31270394 | Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IRA axis in malignant mesothelioma. | Oncogene | 2019 | https://conductscience.org/library/papers/31270394 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29933129
GET https://conductscience.org/api/papers/v1/29933129/references?page=2